Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Complex biotherapeutics interact with many different molecules in the human body to develop their mode of action.

This increases the possibility of unwanted effects which might result in an unacceptable safety profile or compromise therapeutic efficacy of a compound.  Bioassay offers a panel of assays for assessment of monoclonal antibodies to any kind of recombinant proteins to characterize biotherapeutics in this respect.


Antibody-dependent cellular cytotoxicity (ADCC)

  • Neutralizing Antibodies
  • Multi-Cytokine Analysis
  • Immuntoxicology (ITOX3-Panel)
  • Skin Sensitization assays (LLNA, h-Clat & MUSST)
  • Toxicokinetics


  • Testing acc. to Pharm.Eur. 2.6.14
  • Turbidimetric & chromogenic

More About This Company


We provide a number of bioanalytical services, including Immunotoxicity. Immunotoxicity is defined as adverse effects...